Disrupting TNF signaling in pancreatic cancer: A phase I/II clinical study in patients with advanced disease.

被引：0
|
作者：
Kosuri, KV [1 ]
Bekaii-Saab, T [1 ]
Bender, J [1 ]
Criswell, T [1 ]
Kane, Y [1 ]
Chidiac, T [1 ]
Young, D [1 ]
Guttridge, D [1 ]
Caligiuri, M [1 ]
Villalona-Calero, M [1 ]
机构：
[1] Ohio State Univ, James Carter Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：333S / 333S
页数：1
相关论文
共 50 条
  • [21] Phase II trial of curcumin in patients with advanced pancreatic cancer
    Dhillon, Navneet
    Aggarwal, Bharat B.
    Newman, Robert A.
    Wolff, Robert A.
    Kunnumakkara, Ajaikumar B.
    Abbruzzese, James L.
    Ng, Chaan S.
    Badmaev, Vladimir
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4491 - 4499
  • [22] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [23] Phase II Study of Cetuximab and Radiotherapy in Patients with Locally Advanced Pancreatic Cancer (PACER Study)
    Rembielak, A.
    Saleem, A.
    Valle, J.
    West, C.
    Jackson, A.
    Crellin, A.
    Whitfield, G.
    Dickinson, C.
    Jain, P.
    Cullen, J.
    Watkins, G.
    Price, P.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 254 - 255
  • [24] Phase I/II clinical study of DFP-17729 as alkalizing agent in patients with metastatic pancreatic cancer
    Ikeda, M.
    Ueno, M.
    Ozaka, M.
    Shimizu, S.
    Nakachi, K.
    Nagashima, F.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S139 - S139
  • [25] A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer
    Syrigos, KN
    Michalaki, B
    Alevyzaki, F
    Machairas, A
    Mandrekas, D
    Kindilidis, K
    Karatzas, G
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3583 - 3588
  • [26] Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
    P Corrie
    A Mayer
    J Shaw
    S D'Ath
    S Blagden
    C Blesing
    P Price
    N Warner
    British Journal of Cancer, 2002, 87 : 716 - 719
  • [27] Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
    Corrie, P
    Mayer, A
    Shaw, J
    D'Ath, S
    Blagden, S
    Blesing, C
    Price, P
    Warner, N
    BRITISH JOURNAL OF CANCER, 2002, 87 (07) : 716 - 719
  • [28] Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.
    Chang, HM
    Kim, TW
    Ahn, JH
    Ryu, MH
    Lee, JS
    Kim, WK
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [29] Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer
    Jivesh J. Sharma
    Betty Razvillas
    C.D. Stephens
    Susan G. Hilsenbeck
    Ashu Sharma
    Mace L. Rothenberg
    Investigational New Drugs, 1997, 15 : 361 - 364
  • [30] Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: A multicenter phase II study
    Androulakis, N
    Syrigos, K
    Polyzos, A
    Aravantinos, G
    Stathopoulos, GP
    Ziras, N
    Mallas, K
    Vamvakas, L
    Georgoulis, V
    CANCER INVESTIGATION, 2005, 23 (01) : 9 - 12
12345